Akebia Therapeutics, Inc.
看多
已更新

AKBA Long

213
Weekly Demand Zone
Entry 2.47
Stop 1.9
Target 5

Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
交易進行
Buy 2022 Jan C2.5/5 0.45 x4
No stop
Max RRR 4:1

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。